Sbh International Equity FundCIQRX
Type
Mutual fund
Peer group
International equity
Net assets
$14.0M
Expense ratio
0.99%
1-year return
+33.1%
3 years, a year
—
5 years, a year
—
Holdings
338
What it aims to do.
The Segall Bryant & Hamill International Equity Fund (the SBH International Equity Fund or Fund) seeks to achieve long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Roche Holding AG | 2.29% |
| Novartis AG | 1.85% |
| ASML ASML Holding N.V. | 1.67% |
| Banco Bilbao Vizcaya Argentaria SA | 1.60% |
| GSK plc | 1.55% |
| BNP Paribas SA | 1.44% |
| ITOCHU Corp. | 1.37% |
| NatWest Group PLC | 1.27% |
| Siemens Energy AG | 1.27% |
| Danske Bank A/S | 1.26% |
More on CIQRX.
- CIQRX overview
- CIQRX holdings
- CIQRX risk
- CIQRX costs
- CIQRX money in and out
- CIQRX share classes
- Compare CIQRX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.